Back to Results
First PageMeta Content
Property law / Disclaimer / G 1/03 and G 2/03 / Disclosure of the invention under the European Patent Convention / Amendments under the European Patent Convention / European Patent Convention / Appeal procedure before the European Patent Office / Novelty / Claim / European Patent Organisation / Law / Civil law


BESCHWERDEKAMMERN DES EUROPÄISCHEN PATENTAMTS BOARDS OF APPEAL OF THE EUROPEAN PATENT
Add to Reading List

Document Date: 2011-06-14 11:50:44

Open Document

File Size: 77,96 KB

Share Result on Facebook

City

Rahway New Jersey / St. Louis / London / /

Company

Merck & Co. Inc. / Appeal Chambres / Appeal / APPEAL OF THE EUROPEAN PATENT OFFICE CHAMBRES DE RECOURS / BTG Ltd / BESCHWERDEKAMMERN / Monsanto Company / Appeal 3 / /

Country

United States / /

Facility

IRC Building / Health Sciences Mall / University of British Columbia Room / UNIVERSITY OF BRITISH COLUMBIA Relevant / University of British Columbia Opponents / /

IndustryTerm

pharmaceutical formulation / treatment of Alzheimer's disease / treatment of Alzheimer's / treatment of the same illness / /

MedicalCondition

dementia / same illness / Alzheimer's disease / Alzheimer's dementia / senile dementia / /

Organization

Enlarged Board of Appeal / EPC / European Patent Office Office / European Patent Office / Technical Board of Appeal / University of British Columbia / Environmental Protection Agency / /

Person

U. Oswald H. Kellner / /

Position

Chairman / physician / Representative / scientist / Proprietor / /

Product

Eastwick Road Harlow Essex CM20 / diflunisal / oxyphenbutazone / phenylbutazone / ketoprofen / sulindac / ibuprofen / flurbiprofen / naproxen / piroxicam / indomethacin / /

ProgrammingLanguage

L / C / /

ProvinceOrState

Missouri / /

SocialTag